| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.272.47.29590 |
| P698 | PubMed publication ID | 9368023 |
| P2093 | author name string | Juliano L | |
| Juliano MA | |||
| Dubé JY | |||
| Tremblay RR | |||
| Gauthier F | |||
| Bourgeois L | |||
| Deperthes D | |||
| Brillard-Bourdet M | |||
| P2860 | cites work | Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen | Q24294463 |
| Complexes of tissue kallikrein with protein C inhibitor in human semen and urine | Q24313486 | ||
| Purification of enzymatically active kallikrein hK2 from human seminal plasma | Q24321724 | ||
| Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments | Q24528224 | ||
| Substrate specificity of two kallikrein family gene products isolated from the rat submaxillary gland | Q28249153 | ||
| Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen | Q28285751 | ||
| Effects of secondary interactions on the kinetics of peptide and peptide ester hydrolysis by tissue kallikrein and trypsin | Q28302190 | ||
| Characterization of the human kallikrein locus | Q31172280 | ||
| Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate | Q34557677 | ||
| Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum | Q35321298 | ||
| Interaction of subtilisins with serpins | Q36279815 | ||
| Molecular biology of tissue kallikrein | Q39532500 | ||
| Human urinary kallikrein | Q40330612 | ||
| A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein | Q40921349 | ||
| Divining the serpin inhibition mechanism: a suicide substrate 'springe'? | Q40964677 | ||
| Differential interactions of human kallikrein-binding protein and alpha 1-antitrypsin with human tissue kallikrein | Q41807954 | ||
| Determinants of the unusual cleavage specificity of lysyl-bradykinin-releasing kallikreins | Q42824024 | ||
| New specific assays for tonin and tissue kallikrein activities in rat submandibular glands. Assays reveal differences in the effects of sympathetic and parasympathetic stimulation on proteinases in saliva | Q54273715 | ||
| Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies | Q54614756 | ||
| Modeling of Prostate-Specific Antigen and Human Glandular Kallikrein Structures | Q58533598 | ||
| P433 | issue | 47 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 29590-29595 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2. | |
| P478 | volume | 272 |
| Q24324426 | A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation |
| Q36697462 | Activatable Optical Probes for the Detection of Enzymes |
| Q35748176 | Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2. |
| Q42669799 | Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. |
| Q33620984 | Crucial role of estrogen for the mammalian female in regulating semen coagulation and liquefaction in vivo. |
| Q43975984 | Design of new and sensitive fluorogenic substrates for human kallikrein hK3 (prostate-specific antigen) derived from semenogelin sequences. |
| Q31036435 | Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates. |
| Q42156774 | Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins. |
| Q24301375 | Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates |
| Q36357542 | Effects of urine composition on epithelial Na+ channel-targeted protease activity |
| Q28140072 | Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors |
| Q31161649 | Enzymatic profiling of human kallikrein 14 using phage-display substrate technology |
| Q24316359 | Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14 |
| Q81411971 | Human seminal proteinase and prostate-specific antigen are the same protein |
| Q43151753 | Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides |
| Q33947270 | Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3. |
| Q34457491 | Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs). |
| Q30696817 | New, sensitive fluorogenic substrates for human cathepsin G based on the sequence of serpin-reactive site loops. |
| Q33235991 | Novel peptide inhibitors of human kallikrein 2. |
| Q86940902 | Partial genetic deficiency in tissue kallikrein impairs adaptation to high potassium intake in humans |
| Q34033258 | Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers |
| Q38571586 | Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system |
| Q74033127 | Purification and characterization of active recombinant rat kallikrein rK9 |
| Q42993405 | Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids |
| Q30605285 | Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity. |
| Q31068008 | Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology |
| Q46830854 | Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects |
| Q38362486 | Unleashing the therapeutic potential of human kallikrein-related serine proteases |
Search more.